Amanda Alexander, Pharm.D. Email & Phone Number

United States

• Co-founded MatrixArch Capital, leading strategic acquisitions of commercial real estate and small businesses for legacy wealth building.• Developed investment strategies for residential and commercial properties, focusing on long-term growth and profitability.• Negotiated deals and partnerships to expand the company's portfolio and increase revenue streams.

South San Francisco, California, United States

Chief of Staff to the Vice President and Operations & Administration Director for two Squads (cross functional leadership teams) and therapeutic area networks.The Rare Blood Disorders (RBD) Squad sets the U.S. Commercial, Medical, and Government Affairs (CMG) strategy for HEMLIBRA and other pipeline assets as they approach U.S. Commercialization. The Neurological Rare Disease (NRD) Squad sets the CMG strategy for EVRYSDI and other pipeline assets as they approach U.S. Commercialization.

Chief of Staff to the VP & Leadership of a team responsible for key relationships with U.S. Payers/Employers, PBMs, SPs, NCCN, and other MCOs/ healthcare influencers.Managing a team that leads business planning, implementing New Ways of Working, and enhancing field execution on roughly $16B of GNE revenue across the portfolio.

Strategic thought partner to the VP & Leadership of a team responsible for key relationships with U.S. Payers, PBMs, SPs and other managed care organizations/ healthcare influencers.-2020 Pinnacle Award Winner for extraordinary accomplishment and impact across ecosystems and operationsCore accountabilities: internal alignment, business planning, communications, project/program management, synthesis of qualitative intel, shaping field objectives & priorities, enhancing field execution on goals, managing rewards & incentives for field performance, and pull-through of org operating principles.

Ssf

-Transformed our customer-facing model across Commercial & Medical via agile methodology-Effectively balanced local customization with streamlined centralization-Trailblazer Award Winner 2020Specifically responsible for:1. Re-defining & re-structuring a new, innovative Field Operations department (co-lead)2. Aligning the organization to nationwide field objectives and priorities by leading a (director-level) cross-functional team to design the field onboarding experience

Western United States

Responsible for regional business analytics and operations across 28 states, in partnership with region and division leaders-'Earn' Award Winner 2019, for Innovation & Achieving Results, peer-nominated by Region

Northern California & Reno

Representing Alecensa (alectinib), TECENTRIQ (atezolizumab), Rozlytrek (entrectinib)-Essence Award Winner 2019, peer-nominated by Division-Exceptional Collaboration Award Winner 2019, selected by National Senior Leadership-Region Nominee 2019 for Patient Advocacy-Region Nominee 2019 for Teamwork & Collaboration

San Francisco Bay Area

[CRDP] Product Promotion to HCPs; Competitive Readiness; Speaker Bureau Lead

San Francisco Bay Area

Genentech's highly selective business leadership track [more info: https://tinyurl.com/CRDPvideo]

San Francisco Bay Area

[CRDP] * Led the execution of a patient adherence program in conjunction with Novartis* Collaborated with medical, legal, regulatory and lead agency partners to create patient-friendly materials; leveraging market research to refine project deliverables

San Francisco Bay Area

[CRDP] * Identified areas of opportunity for standardization and specialization of field-facing technology platforms across Business Units and Managed Care Customer Operations teams* Developed processes to support the above teams and led efforts to align the organization

Central America & The Caribbean

[CRDP] Market segmentation and launch strategy -- specifically: market planning, field force training, competitive intelligence/competitive readiness, and various internal campaigns

San Francisco Bay Area

* Led weekly conferences for fifteen second-year student pharmacists* Taught navigation techniques in UCSF's EPIC System: Advanced Patient-Centered Excellence (APeX)* Provided reviews of cardiology topics including dyslipidemia, diabetes, hypertension, venous thromboembolism, stroke, and heart failure* Demonstrated appropriate uses of drug information resources (LexiComp®), clinical practice guidelines, and primary literature to identify relevant information for therapeutic monitoring/evaluation of medication(s)

San Francisco Bay Area

* Executed initial phases of UCSF's transitions of care model* Peer-to-peer preceptorship of IPPE students; tracked performance; elicited two-way feedback* Provided hands-on EPIC training for students of the schools of pharmacy and medicine* Identified patients who could benefit from clinic services; staged appropriate outreach* Conducted comprehensive medication reviews with patients and caregivers* Coordinated continuity of care with other members of the patient's health care team

San Francisco Bay Area

* Assisted in the unique experience of a cross-city hospital move: setting up an entirely new pharmacy at Mission Bay and converting pediatric wards into flex wards for adults at Parnassus* Attended pharmacy & therapeutics committee meetings; conferences with directors of pharmacy* Responded to drug information inquiries by performing literature reviews and contacting authors of related research to elucidate off-label uses of (1) intravitreal rituximab for vitreoretinal lymphoma and (2) bladder instillations for interstitial cystitis* Conducted strict inventories, Pyxis fills and audits* Shadowed investigational drug pharmacists in the operations behind clinical trial management

San Francisco, Ca

* Services focused on special populations including transplant, oncology and pediatric patients* Administered various immunizations, including influenza, Hep A/B, and travel vaccinations* Counseled patients on prescriptions, medical devices and over-the-counter recommendations* Designed a program for patient access to high-cost medications* Performed compounding of specialty drugs

San Francisco, Ca

• Completed patient medication reconciliation upon admission and at discharge• Assisted surgeons in discharge instructions and medication planning for patients after surgery• Provided face-to-face consultations to post-operative patients and their caregivers

Foster City, California

• Counseled patients, performed immunizations, and provided OTC recommendations• Processed coverage alternatives such as PAs, manufacturer coupons, insurance overrides• Evaluated patient profiles to reconcile adherence issues or potential drug and disease interactions• Transcribed written, electronic, and verbal prescriptions and facilitated prescription transfers• Medication production, simple compounding, dispensing and inventory maintenance

San Francisco, Ca

• Optimized drug selection and dosing regimens given patient-specific parameters• Monitored 12 patients daily for drug or disease interactions, side effects, and efficacies• Gave face-to-face consultations for patients on anticoagulants or new insulin regimens• Expedited prior authorizations for outpatient medications• Effectively communicated with interdisciplinary teams in a public tertiary medical center

Silver Spring, Md

• Analyzed all anti-cancer agents FDA-approved since 2011 through federal regulatory documents• Summarized data reviews submitted by the manufacturer from early phase (I/II) clinical trials• Outlined instructions for reproducibility to allow the Center for Drug & Evaluation Research to readily re-evaluate the appropriateness of labeled doses currently being used on the market

San Francisco, Ca

• Rounded daily with expert physicians as part of a consult service to a tertiary hospital • Applied primary literature as evidence for or against the uses of antimicrobial agents• Optimized dosing given patient renal or hepatic status and concomitant drugs• Monitored hospital usage of broad-spectrum antibiotics daily and communicated recommendations on narrowing or dosing to interdisciplinary teams as part of antimicrobial stewardship

1 Dna Way, South San Francisco, Ca

The Health Economics & Outcomes Research (HEOR) group provides economic assessments and related evidence throughout the life cycle of Genentech molecules. This information complements data on efficacy and safety to demonstrate a value proposition in the context of competitive environments.* Retrospectively analyzed electronic health data using biostatistical software (Stata 13)* Investigated innovative adherence technology in proposal of its implementation in clinical trials* Performed literature reviews and created succinct documents/slide presentations of key aspects for influencing further research strategies* Presented findings internally to disease state specialists and senior health economists

1 Dna Way, South San Francisco, Ca

The Global Product Strategy, Global Pricing and Market Access team contributes to the successful commercialization of Roche molecules by providing economic assessments and related evidence throughout the life cycle of our therapeutic agents.* Reviewed and evaluated European appraisals of molecules exiting the pipeline* Highlighted key evidence-based insights into a report for internal archives* Presented findings and recommendations to a variety of internal audiences (International Payer Strategy Leaders, Disease Area Directors, Strategic Insight Managers, Core Teams, Integrated Commercial and Development Plan Teams, Regulatory, Clinical) to ensure clinical development is optimized for successful market access and pricing negotiations at the time of product launch

San Francisco, Ca

• Optimized reporting in closed health system via visual presentations of managed care data• Input variables from descriptive documents covering residency objectives into a datasheet in order to better streamline facets of Kaiser training programs that meet or exceed accreditation standards• Created media such as posters and flyers to educate patients on the importance of programming an ICE (In Case of Emergency) contact into smart-phones

Doctor Of Pharmacy (Pharm.D.), Pharmacy

Bachelor Of Science (Bs), Molecular, Cellular & Developmental Biology, Summa Cum Laude